VSee Health entered two unsecured convertible note financings totaling $575,550 to strengthen liquidity. The company issued a $280,000 note to ClearThink with a one-time 10% interest charge, and a $295,550 note to Vanquish with a one-time 12% interest charge. The ClearThink note matures on Jun 22, 2027 and is prepayable without penalty, with conversion after 180 days at 85% of the lowest 10-day closing price, subject to a $0.01 floor and a 4.99% ownership cap. The Vanquish note is due Apr 15, 2027, features prepayment premiums, and allows conversion after 180 days and upon an event of default at 75% of the lowest 10-day closing bid, with a 4.99% cap and no reverse-split adjustment.
Agreement 1: VSee Health Secures $280,000 ClearThink Convertible Note; 10% One-Time Interest, 2027 Maturity
- Agreement type: Unsecured convertible note
- Counterparty: ClearThink
- Signed / Effective: Jun 22 2026 / same
- Duration / Termination: Due Jun 22 2027
- Reason: Enhance liquidity and financial flexibility
Agreement 2: VSee Health Adds $295,550 Vanquish Convertible Note; 12% One-Time Interest, Apr 2027 Due
- Agreement type: Unsecured convertible note
- Counterparty: Vanquish
- Signed / Effective: Jun 18 2026 / same
- Duration / Termination: Due Apr 15 2027
- Reason: Enhance liquidity and financial flexibility
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.